CYP4F2 (cytochrome P450 family 4 subfamily F member 2)

2014-09-01  

Identity

HGNC
LOCATION
19p13.12
LOCUSID
ALIAS
CPF2

Other Information

Locus ID:

NCBI: 8529
MIM: 604426
HGNC: 2645
Ensembl: ENSG00000186115

Variants:

dbSNP: 8529
ClinVar: 8529
TCGA: ENSG00000186115
COSMIC: CYP4F2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000186115ENST00000011989A0A0A0MQR0
ENSG00000186115ENST00000221700P78329
ENSG00000186115ENST00000586927K7EK90
ENSG00000186115ENST00000587671K7EPM0
ENSG00000186115ENST00000589654K7EQI8

Expression (GTEx)

0
10
20
30
40
50
60
70
80
90
100

Pathways

PathwaySourceExternal ID
Arachidonic acid metabolismKEGGko00590
Arachidonic acid metabolismKEGGhsa00590
Metabolic pathwaysKEGGhsa01100
MetabolismREACTOMER-HSA-1430728
Metabolism of lipids and lipoproteinsREACTOMER-HSA-556833
Arachidonic acid metabolismREACTOMER-HSA-2142753
Synthesis of Leukotrienes (LT) and Eoxins (EX)REACTOMER-HSA-2142691
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)REACTOMER-HSA-2142816
Biological oxidationsREACTOMER-HSA-211859
Phase 1 - Functionalization of compoundsREACTOMER-HSA-211945
Cytochrome P450 - arranged by substrate typeREACTOMER-HSA-211897
Fatty acidsREACTOMER-HSA-211935
EicosanoidsREACTOMER-HSA-211979
Miscellaneous substratesREACTOMER-HSA-211958

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA126CYP2C9GeneDataAnnotationassociated
PA130620651anthracyclines and related substancesChemicalClinicalAnnotationassociatedPD21900104, 23441093
PA133787052VKORC1GeneDataAnnotationassociated
PA153619833Peripheral Vascular DiseasesDiseaseClinicalAnnotationassociatedPKPD18250228, 19207028, 19297519, 19300499, 19741565, 19794411, 20072124, 20128861, 20182420, 20421126, 20442691, 20653676, 20833655, 21084764, 21127708, 21174619, 21228733, 21326313, 21383771, 21725053, 22010099, 22130800, 22172097, 22192158, 22528326, 22534826, 22549502, 22676192, 22871975, 23061746, 23104259, 23132553, 23215885, 23949431, 23990957, 24019055, 24029542, 24330000, 24601977, 25042728, 25084205, 25126975, 25594941, 26024874, 26223945, 26257249, 26710337, 26739746, 26745506, 26877068, 27073641, 27121899, 27262824, 27488389, 27617219, 27938396, 28049362, 28262345, 28429387, 28550460, 28620303, 28973620, 29054760, 29201113, 29252193, 29432897, 29875668
PA164713404Vitamin KChemicalClinicalAnnotation, VipGeneassociatedPK27061505, 27462768, 27488389, 28262345, 29252193, 29273767, 18841274, 19297519, 28521079
PA165108401Acute coronary syndromeDiseaseClinicalAnnotationassociatedPD24418943, 25712182
PA165816543CYP2C9*2HaplotypeGuidelineAnnotationassociated
PA165816544CYP2C9*3HaplotypeGuidelineAnnotationassociated
PA165816546CYP2C9*5HaplotypeGuidelineAnnotationassociated
PA165816547CYP2C9*6HaplotypeGuidelineAnnotationassociated
PA165816549CYP2C9*8HaplotypeGuidelineAnnotationassociated
PA165816552CYP2C9*11HaplotypeGuidelineAnnotationassociated
PA165860687CYP4F2*3HaplotypeVipGeneassociated19132230, 20072124, 20182420, 20555338, 22417713, 22855348, 24956252, 25042728, 14638353
PA166122486db-289ChemicalVipGeneassociated
PA166123298over-anticoagulationDiseaseClinicalAnnotationassociatedPD22417713, 23104259, 24911077, 28049362
PA166129532time to therapeutic inrDiseaseVariantAnnotationassociatedPD29396738
PA166154157rs12777823VariantGuidelineAnnotationassociated
PA166155091rs9923231VariantGuidelineAnnotationassociated
PA166155381rs2108622VariantGuidelineAnnotation, VipGeneassociated19132230, 20072124, 20182420, 20555338, 22417713, 22855348, 24956252, 25042728, 14638353
PA166197681Vitamin K1ChemicalClinicalAnnotationassociatedPK31134657
PA28660GGCXGeneDataAnnotationassociated
PA443459Atrial FibrillationDiseaseClinicalAnnotation, VariantAnnotationassociatedPD19270263, 19578179, 22486182, 23510058, 24956252, 25042728, 25519826, 29396738, 29432897, 29479633
PA444417HemorrhageDiseaseClinicalAnnotation, VariantAnnotationassociatedPKPD18250228, 19207028, 19297519, 19300499, 19741565, 19794411, 20072124, 20128861, 20182420, 20421126, 20442691, 20653676, 20833655, 21084764, 21127708, 21174619, 21228733, 21326313, 21383771, 21725053, 22010099, 22130800, 22172097, 22192158, 22528326, 22534826, 22549502, 22676192, 22871975, 23061746, 23104259, 23132553, 23215885, 23949431, 23990957, 24019055, 24029542, 24330000, 24601977, 25042728, 25084205, 25126975, 25594941, 26024874, 26223945, 26257249, 26710337, 26739746, 26745506, 26877068, 27073641, 27121899, 27262824, 27488389, 27617219, 27938396, 28049362, 28262345, 28429387, 28550460, 28620303, 28973620, 29054760, 29201113, 29252193, 29432897, 29875668
PA445019Myocardial InfarctionDiseaseClinicalAnnotationassociatedPKPD18250228, 19207028, 19297519, 19300499, 19741565, 19794411, 20072124, 20128861, 20182420, 20421126, 20442691, 20653676, 20833655, 21084764, 21127708, 21174619, 21228733, 21326313, 21383771, 21725053, 22010099, 22130800, 22172097, 22192158, 22528326, 22534826, 22549502, 22676192, 22871975, 23061746, 23104259, 23132553, 23215885, 23949431, 23990957, 24019055, 24029542, 24330000, 24601977, 25042728, 25084205, 25126975, 25594941, 26024874, 26223945, 26257249, 26710337, 26739746, 26745506, 26877068, 27073641, 27121899, 27262824, 27488389, 27617219, 27938396, 28049362, 28262345, 28429387, 28550460, 28620303, 28973620, 29054760, 29201113, 29252193, 29432897, 29875668
PA445062NeoplasmsDiseaseClinicalAnnotationassociatedPD21900104, 23441093
PA445848ThromboembolismDiseaseClinicalAnnotationassociatedPKPD18250228, 19207028, 19297519, 19300499, 19741565, 19794411, 20072124, 20128861, 20182420, 20421126, 20442691, 20653676, 20833655, 21084764, 21127708, 21174619, 21228733, 21326313, 21383771, 21725053, 22010099, 22130800, 22172097, 22192158, 22528326, 22534826, 22549502, 22676192, 22871975, 23061746, 23104259, 23132553, 23215885, 23949431, 23990957, 24019055, 24029542, 24330000, 24601977, 25042728, 25084205, 25126975, 25594941, 26024874, 26223945, 26257249, 26710337, 26739746, 26745506, 26877068, 27073641, 27121899, 27262824, 27488389, 27617219, 27938396, 28049362, 28262345, 28429387, 28550460, 28620303, 28973620, 29054760, 29201113, 29252193, 29432897, 29875668
PA446997Intracranial HemorrhagesDiseaseClinicalAnnotationassociatedPKPD18250228, 19207028, 19297519, 19300499, 19741565, 19794411, 20072124, 20128861, 20182420, 20421126, 20442691, 20653676, 20833655, 21084764, 21127708, 21174619, 21228733, 21326313, 21383771, 21725053, 22010099, 22130800, 22172097, 22192158, 22528326, 22534826, 22549502, 22676192, 22871975, 23061746, 23104259, 23132553, 23215885, 23949431, 23990957, 24019055, 24029542, 24330000, 24601977, 25042728, 25084205, 25126975, 25594941, 26024874, 26223945, 26257249, 26710337, 26739746, 26745506, 26877068, 27073641, 27121899, 27262824, 27488389, 27617219, 27938396, 28049362, 28262345, 28429387, 28550460, 28620303, 28973620, 29054760, 29201113, 29252193, 29432897, 29875668
PA447288Essential hypertensionDiseaseVipGeneassociated18971550
PA447298venous thromboembolismDiseaseClinicalAnnotationassociatedPKPD18250228, 19207028, 19297519, 19300499, 19741565, 19794411, 20072124, 20128861, 20182420, 20421126, 20442691, 20653676, 20833655, 21084764, 21127708, 21174619, 21228733, 21326313, 21383771, 21725053, 22010099, 22130800, 22172097, 22192158, 22528326, 22534826, 22549502, 22676192, 22871975, 23061746, 23104259, 23132553, 23215885, 23949431, 23990957, 24019055, 24029542, 24330000, 24601977, 25042728, 25084205, 25126975, 25594941, 26024874, 26223945, 26257249, 26710337, 26739746, 26745506, 26877068, 27073641, 27121899, 27262824, 27488389, 27617219, 27938396, 28049362, 28262345, 28429387, 28550460, 28620303, 28973620, 29054760, 29201113, 29252193, 29432897, 29875668
PA448497aspirinChemicalClinicalAnnotationassociatedPD24418943, 25712182
PA449045clofibrateChemicalVipGeneassociated11061988, 11997390, 15753130, 17142457, 10860554
PA449053clopidogrelChemicalClinicalAnnotationassociatedPD24418943, 25712182
PA450146ketoconazoleChemicalVipGeneassociated15753130
PA450272lovastatinChemicalVipGeneassociated17142457
PA450921phenprocoumonChemicalClinicalAnnotationassociatedPKPD21063236, 23510058
PA451900vitamin eChemicalClinicalAnnotation, VipGeneassociatedPK15753130, 18433732, 11997390, 17341693, 20861217, 24138531, 24759732
PA451906warfarinChemicalClinicalAnnotation, DataAnnotation, GuidelineAnnotation, Literature, MultilinkAnnotation, VariantAnnotation, VipGeneambiguousPKPD18391101, 18971550, 24984178, 27061505, 27462768, 27488389, 28262345, 29252193, 29273767, 17341693, 18250228, 19207028, 19297519, 19300499, 19741565, 19794411, 20072124, 20128861, 20182420, 20421126, 20442691, 20653676, 20833655, 21084764, 21127708, 21174619, 21228733, 21326313, 21383771, 21725053, 22010099, 22130800, 22172097, 22192158, 22417713, 22528326, 22534826, 22549502, 22676192, 22871975, 23061746, 23104259, 23132553, 23215885, 23949431, 23990957, 24019055, 24029542, 24330000, 24601977, 24911077, 25042728, 25084205, 25126975, 25594941, 26024874, 26223945, 26257249, 26710337, 26739746, 26745506, 26877068, 27073641, 27121899, 27262824, 27488389, 27617219, 27938396, 28049362, 28079798, 28262345, 28429387, 28550460, 28620303, 28973620, 29054760, 29201113, 29252193, 29396738, 29432897, 29875668
PA452632acenocoumarolChemicalClinicalAnnotation, DataAnnotation, Literature, VipGeneassociatedPD27061505, 27462768, 27488389, 28262345, 29252193, 29273767, 19132230, 19270263, 19578179, 22486182, 23510058, 24956252, 25042728, 25089947, 25519826, 29432897, 29479633
PA55APOEGeneDataAnnotationassociated

References

Pubmed IDYearTitleCitations
193004992009A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose.211
193004992009A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose.211
182502282008CYP4F2 genetic variant alters required warfarin dose.157
182502282008CYP4F2 genetic variant alters required warfarin dose.157
192975192009CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant.92
199131212009Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.85
200721242010Genetic and clinical predictors of warfarin dose requirements in African Americans.78
183911012008A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure.57
183911012008A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure.57
205042532010Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups.52

Citation

Dessen P

CYP4F2 (cytochrome P450 family 4 subfamily F member 2)

Atlas Genet Cytogenet Oncol Haematol. 2014-09-01

Online version: http://atlasgeneticsoncology.org/gene/54891/cyp4f2-(cytochrome-p450-family-4-subfamily-f-member-2)